NASDAQ:QNCX | Profit Breakdown | Quince Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$79.78M-$75.49M
2026-03-31-$14.59M$35.91M
2025-12-31-$19.35M-$39.46M
2025-09-30-$13.43M-$13.44M
2025-06-30-$10.43M-$16.05M
2025-03-31-$14.86M-$14.98M-$15.03M
2024-12-31-$12.01M-$12.46M
2024-09-30-$5.86M-$5.49M
2024-06-30-$28.19M-$27.73M
2024-03-31-$11.22M-$11.12M-$11.15M
2023-12-31-$9.92M-$8.89M
2023-09-30-$6.09M-$5.35M
2023-06-30-$5.58M-$4.89M
2023-03-31-$12.96M-$12.25M
2022-12-31-$6.32M-$5.53M
2022-09-30-$7.62M-$7.92M
2022-06-30-$16.26M-$16.56M
2022-03-31-$21.86M-$21.64M
2021-12-31-$23.54M-$23.4M
2021-09-30-$21.68M-$21.71M
2021-06-30-$21.78M-$21.75M
2021-03-31-$23.31M-$23.09M
2020-12-31-$20.85M-$20.56M
2020-09-30-$21.91M-$21.51M
2020-06-30-$18.27M-$17.61M
2020-03-31-$17.86M-$17.18M
2019-12-31-$12.95M-$12.38M
2019-09-30-$10.57M-$9.86M
2019-06-30-$9.58M-$9.06M
2019-03-31-$6.08M-$5.68M
2018-12-31-$3.84M-$3.47M
2018-09-30-$2.87M-$2.52M
2018-06-30-$2.64M-$3.11M
2018-03-31-$2.76M-$3.38M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$58.07M-$80.77M-$83.98M
2024-12-31-$57.29M-$56.74M-$56.83M
2023-12-31-$34.62M-$31.58M-$31.39M
2022-12-31-$52.02M-$51.94M-$51.66M
2021-12-31-$90.32M-$89.95M-$89.95M
2020-12-31-$78.89M-$76.85M-$76.85M
2019-12-31-$39.17M-$36.98M-$36.98M
2018-12-31-$12.12M-$12.48M